KURA ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.59 USD | +1.53% |
|
+8.37% | +43.18% |
| 05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
| 05-02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KURA ONCOLOGY, INC. | Bio Therapeutic Drugs | +1.53% | +8.37% | +43.18% | +101.67% | +36.81% | 1.57B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KURA Stock
- Charts Kura Oncology, Inc.
- Comparison Chart
